Ekso Bionics Holdings Inc (EKSO)

[skepticone]

Thereafter, if such a company does not regain compliance with the bid price requirement a second 180-day compliance period may be
available. A company listed on the Nasdaq Capital Market may be eligible for an additional 180-day compliance period if it meets the
market value of publicly held shares requirement for continued listing, all other initial inclusion requirements for the Capital Market, except
for the bid price requirement, and provides written notice that it intends to regain compliance with the bid price requirement during the
second 180-day compliance period, by effecting a reverse stock split if necessar


What happens if a company does not regain compliance with the minimum bid price requirement during the compliance
period?
Identification
Number 358
If a company is unable to resolve its bid price deficiency during the applicable compliance period, Nasdaq Staff will issue a delisting letter.
At that time, the company may request a hearing before a Hearing Panel, which will stay the delisting.
The company will have the opportunity to present its plan to regain compliance to the Panel. This plan of compliance should include the
implementation of a reverse stock split in the near term. In appropriate cases, and so long as a company commits to implementation of a
reverse split within 180 days of the delisting notification, Panels may also consider other factors, such as the company's fundamental
financial strengths and weaknesses, the overall market conditions, the company's historical bid price, and impending disclosures,
corporate actions and strategic business plans that the company believes may impact its bid